Indiana Life Sciences Capital: A Summary of 2019 Investments

thumbnail of 2019 BioCrossroads Life Sciences Capital Report
April 21, 2020

An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019. The report details information on the types of funding, the companies who received capital, how much was funded, and the funders.